ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.305,57
-0,34%
S&P 500
5.304,72
0,70%
US Dollar vs BRL
5,13862
-0,55%
Bitcoin
69.316,89
1,15%
Brent Oil
81,965
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. NeuroMetrix Inc (NURO)

  7. NeuroMetrix Inc (NURO) Notícias

NURO

NeuroMetrix (NURO)

NeuroMetrix Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NURO
DataHoraFonteTítuloCódigoCompanhia
24/05/202418:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NURONeuroMetrix Inc
15/05/202417:00GlobeNewswire Inc.NeuroMetrix Reports Q1 2024 Business HighlightsNASDAQ:NURONeuroMetrix Inc
15/05/202413:33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NURONeuroMetrix Inc
15/05/202412:19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NURONeuroMetrix Inc
19/04/202409:00GlobeNewswire Inc.NeuroMetrix Announces Steps Taken to Enhance Shareholder ValueNASDAQ:NURONeuroMetrix Inc
14/03/202410:00GlobeNewswire Inc.NeuroMetrix Announces Publication of Study Demonstrating that DPNCheck Accurately Diagnoses Diabetic Peripheral NeuropathyNASDAQ:NURONeuroMetrix Inc
13/03/202410:00GlobeNewswire Inc.NeuroMetrix announces that over 2000 patients with fibromyalgia have been prescribed Quell® FibromyalgiaNASDAQ:NURONeuroMetrix Inc
04/03/202418:12Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NURONeuroMetrix Inc
01/03/202419:07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NURONeuroMetrix Inc
27/02/202418:45Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:NURONeuroMetrix Inc
27/02/202418:00Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:NURONeuroMetrix Inc
22/02/202409:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NURONeuroMetrix Inc
22/02/202409:00GlobeNewswire Inc.NeuroMetrix Reports Q4 and Full Year 2023 Business HighlightsNASDAQ:NURONeuroMetrix Inc
20/02/202416:49Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NURONeuroMetrix Inc
15/02/202411:00GlobeNewswire Inc.NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2023 Business Highlights Conference CallNASDAQ:NURONeuroMetrix Inc
13/02/202411:00GlobeNewswire Inc.NeuroMetrix Announces Review of Strategic Options to Promote Growth and Maximize Shareholder ValueNASDAQ:NURONeuroMetrix Inc
12/12/202311:00GlobeNewswire Inc.NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)NASDAQ:NURONeuroMetrix Inc
05/12/202311:00GlobeNewswire Inc.NeuroMetrix Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Showing that Quell® Improves Painful Symptoms of Chemotherapy Induced Peripheral Neuropathy (CIPN)NASDAQ:NURONeuroMetrix Inc
20/11/202311:00GlobeNewswire Inc.NeuroMetrix Announces One-for-Eight Reverse Stock SplitNASDAQ:NURONeuroMetrix Inc
26/10/202308:00GlobeNewswire Inc.NeuroMetrix Reports Q3 2023 Business HighlightsNASDAQ:NURONeuroMetrix Inc
23/10/202312:13GlobeNewswire Inc.NeuroMetrix, Inc. Announces Date for Third Quarter 2023 Business and Financial Highlights Conference CallNASDAQ:NURONeuroMetrix Inc
02/10/202310:00GlobeNewswire Inc.NeuroMetrix and the National Fibromyalgia Association to Collaborate to Improve the Quality of Life for People Living with FibromyalgiaNASDAQ:NURONeuroMetrix Inc
11/09/202308:59Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:NURONeuroMetrix Inc
27/07/202308:00GlobeNewswire Inc.NeuroMetrix Reports Q2 2023 Business HighlightsNASDAQ:NURONeuroMetrix Inc
20/07/202314:00GlobeNewswire Inc.NeuroMetrix, Inc. Announces Date for Second Quarter 2023 Business and Financial Highlights Conference CallNASDAQ:NURONeuroMetrix Inc
11/07/202310:00GlobeNewswire Inc.NeuroMetrix Announces Sales Force Expansion for Quell FibromyalgiaNASDAQ:NURONeuroMetrix Inc
28/06/202310:00GlobeNewswire Inc.Recent Publications Demonstrate Utility of DPNCheck® for Identifying High-Risk Diabetes PatientsNASDAQ:NURONeuroMetrix Inc
07/06/202310:00GlobeNewswire Inc.Diabetic Peripheral Neuropathy Screening That Includes DPNCheck® Predicts Mortality In A Prospective Clinical StudyNASDAQ:NURONeuroMetrix Inc
31/05/202318:22Edgar (US Regulatory)Specialized Disclosure Report (sd)NASDAQ:NURONeuroMetrix Inc
31/05/202310:00GlobeNewswire Inc.Quell® Demonstrates Encouraging Clinical Trial Results in Chemotherapy Induced Peripheral Neuropathy (CIPN)NASDAQ:NURONeuroMetrix Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:NURO

Seu Histórico Recente

LSE
AIDP
COIN
BTCAUSD
ASX
LYKN
Lykos Metals
COIN
SGTTETH
Sharedstake.finance
ASX
GMLO
Gateway Mining
NYSE
CVSE
Morgan Stanley E
NYSE
PPR
Voya Prime Rate
AMEX
NTSE
Wisdomtree Emerging Mark...
LSE
BMTO
Braime
BITMOT
760477
Eu Tf 2.5% Nv27 Eur
USOTC
CMOT
Curtiss Motorcycles (PK)
ASX
TGNN
LSE
ESCT
The European Smaller Com...
AMEX
MJIN
ETFMG 2x Daily Inverse A...
USOTC
KOSCF
Kose (PK)
ASX
CPK
CP1 Ltd
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados